1. Home
  2. AURA vs BKSY Comparison

AURA vs BKSY Comparison

Compare AURA & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • BKSY
  • Stock Information
  • Founded
  • AURA 2007
  • BKSY 2013
  • Country
  • AURA United States
  • BKSY United States
  • Employees
  • AURA N/A
  • BKSY N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • BKSY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • AURA Health Care
  • BKSY Technology
  • Exchange
  • AURA Nasdaq
  • BKSY Nasdaq
  • Market Cap
  • AURA 370.1M
  • BKSY 303.5M
  • IPO Year
  • AURA 2021
  • BKSY N/A
  • Fundamental
  • Price
  • AURA $6.34
  • BKSY $7.91
  • Analyst Decision
  • AURA Strong Buy
  • BKSY Strong Buy
  • Analyst Count
  • AURA 4
  • BKSY 5
  • Target Price
  • AURA $22.75
  • BKSY $21.80
  • AVG Volume (30 Days)
  • AURA 383.6K
  • BKSY 1.4M
  • Earning Date
  • AURA 03-24-2025
  • BKSY 03-06-2025
  • Dividend Yield
  • AURA N/A
  • BKSY N/A
  • EPS Growth
  • AURA N/A
  • BKSY N/A
  • EPS
  • AURA N/A
  • BKSY N/A
  • Revenue
  • AURA N/A
  • BKSY $102,093,000.00
  • Revenue This Year
  • AURA N/A
  • BKSY $33.53
  • Revenue Next Year
  • AURA N/A
  • BKSY $33.06
  • P/E Ratio
  • AURA N/A
  • BKSY N/A
  • Revenue Growth
  • AURA N/A
  • BKSY 8.04
  • 52 Week Low
  • AURA $5.77
  • BKSY $3.86
  • 52 Week High
  • AURA $12.38
  • BKSY $21.92
  • Technical
  • Relative Strength Index (RSI)
  • AURA 34.98
  • BKSY 31.88
  • Support Level
  • AURA $5.77
  • BKSY $8.30
  • Resistance Level
  • AURA $7.73
  • BKSY $9.79
  • Average True Range (ATR)
  • AURA 0.46
  • BKSY 0.67
  • MACD
  • AURA -0.13
  • BKSY 0.03
  • Stochastic Oscillator
  • AURA 29.08
  • BKSY 4.41

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

Share on Social Networks: